| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |